Antibodies to aquaporin-1 are not present in neuromyelitis optica
Although more than 70% of all patients with neuromyelitis optica (NMO) are seropositive for aquaporin-4 (AQP4) antibodies, a substantial proportion of patients fulfilling the clinical criteria for NMO or limited forms of the disease (NMO spectrum disorders [NMOSD]) are negative for these antibodies....
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Journal article |
| Argitaratua: |
American Academy of Neurology
2015
|